Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): A comparison of N-Isopropyl-p-[123I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 562-563

  Ogaki, Kotaro ^a   Motoi, Yumiko ^a   Li, Yuanzhe ^a   Tomiyama, Hiroyuki ^a   Shimizu, Natsue ^b   Takanashi, Masashi ^a   Nakanishi, Atsushi ^a   Yokoyama, Kazumasa ^a   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO HEISEI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; IOFETAMINE I 123; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; TAU PROTEIN; 3 IODO 2 HYDROXY 6 METHOXY N ((1 ETHYL 2 PYRROLIDINYL)METHYL)BENZAMIDE; 3-IODO-2-HYDROXY-6-METHOXY-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZAMIDE; ASPARAGINE; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; LYSINE; MAPT PROTEIN, HUMAN; PYRROLIDINE DERIVATIVE;

ADULT; AGED; APRAXIA; BRADYKINESIA; BRAIN BLOOD FLOW; BRAIN PERFUSION; CHROMOSOME 17; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; EYE MOVEMENT; EYE TRACKING; EYELID MOVEMENT; EYELID OPENING; FEMALE; FRONTOTEMPORAL DEMENTIA; GAIT DISORDER; GASTROSTOMY; GAZE PARALYSIS; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LETTER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; N279K GENE; NEUROIMAGING; NEUROLOGIC EXAMINATION; PARKINSONISM; PATHOPHYSIOLOGY; POSTURAL INSTABILITY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RIGIDITY; SHUFFLING GAIT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VERTICAL GAZE PARALYSIS; VISUAL DISORDER; VISUAL GRASPING; WALKING DIFFICULTY; BRAIN; CASE REPORT; GENETICS; HAND STRENGTH; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SCINTISCANNING;

ADULT; AGED; ASPARAGINE; BENZAMIDES; BRAIN; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HAND STRENGTH; HUMANS; LYSINE; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PYRROLIDINES; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79953281343     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23461     Document Type: Letter

References (7)

1. Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17. Arch Neurol 2008; 65: 460-464.
2. Tsuboi Y, Baker M, Hutton ML, et al. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology 2002; 59: 1791-1793.
3. Ghika J, Tennis M, Growdon J, Hoffman E, Johnson K. Environment-driven responses in progressive supranuclear palsy. J Neurol Sci 1995; 130: 104-111.
4. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238-1248.
5. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
6. Takahashi K, Yamaguchi S, Kobayashi S, Yamamoto Y. Effects of aging on regional cerebral blood flow assessed by using technetium Tc 99m hexamethylpropyleneamine oxime single photon emission tomography with 3D stereotactic surface projection analysis. Am J Neuroradiol 2005; 26: 2005-2009.
7. Richards JE. Cortical sources of event-related potentials in the prosaccade and antisaccade task. Psychophysiology 2003; 40: 878-894.